propranolol

Propranolol hydrochloride is a widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse

(R)-Propranolol hydrochloride (Dexpropranolol hydrochloride) is the less active enantiomer of the anti-adrenoceptor (β-adrenoceptor) antagonist propranolol. Propranolol is a nonselective β-adrenergic receptor (βAR) antagonist with a high affinity for β1AR and β2AR with Ki values of 1.8 nM and 0.8 nM, respectively.

4-Hydroxypropranolol-D7 hydrochloride is deuterium-labeled 4-Hydroxypropranolol hydrochloride. 4-Hydroxypropranolol hydrochloride (T10150) is an active metabolite of Propranolol, with a potency comparable to Propranolol. It inhibits β1- and β2-adrenergic receptors (pA2s: 8.24 and 8.26).

4-Hydroxypropranolol hydrochloride is an active metabolite of Propranolol, with a potency comparable to Propranolol. It inhibits β1- and β2-adrenergic receptors (pA2s: 8.24 and 8.26).

Propranolol-D7 hydrochloride is a deuterated isotope marker of Propranolol hydrochloride (TMSM-1966), which can be used for isotope tracing. Propranolol is a non-selective beta-blocker used for hypertension research

(S)-(-)-Propranolol hydrochloride, an adrenergic receptor antagonist, exhibits potential anticancer activity and may enhance the prognosis of burn patients.

4-Hydroxypropranolol-D7 Hydrochloride (Standard) is a reference standard of 4-Hydroxypropranolol-D7 Hydrochloride intended for quantitative analysis, quality control, and related biochemical research applications.

rac-Propranolol-D7 is a 2H-labeled Rac-Propranolol. Propranolol (TPL0294) is an effective β-adrenergic receptor (βAR) antagonist that inhibits β1AR and β2AR, used in cardiovascular and metabolic disease research.

(±)-4-hydroxy Propranolol β-D-glucuronide is a metabolite of (±)-4-hydroxy propranolol , which is a metabolite of propranolol. The apparent half-life of (±)-4-hydroxy propranolol β-D-glucuronide is similar to propranolol and 4-hydroxy propranolol. Propranolol is a β-adrenergic antagonist, and the active enantiomer, (S)-(-)-propranolol , has log Kd values of -8.16, -9.08, and -6.93 for β1, β2, and β3, respectively.

rac-7-hydroxy Propranolol (hydrochloride) is a ring-hydroxylated isomer and metabolite of propranolol that is an antagonist at β-adrenergic receptors (0.95 potency relative to propranolol). It also demonstrates potent vasodilator activity (0.20 potency relative to propranolol; pA2 = 7.58).

5-hydroxy Propranolol is a metabolite of propranolol , a β-adrenergic receptor antagonist. Propranolol is primarily metabolized in the liver, with cytochrome P450 isoform 2D6 directing ring hydroxylation and the generation of 5-hydroxy propranolol and related metabolites.

Propranolol glycol, a metabolite of propranolol, exhibits transient anticonvulsant activity.

Propranolol-D7 (ring-D7) is a deuterated form of Propranolol (TPL0294) hydrochloride, which is a non-selective β-adrenergic receptor (βAR) antagonist with high affinity for both β1AR and β2AR, having Ki values of 1.8 nM and 0.8 nM, respectively. Propranolol (TPL0294) hydrochloride inhibits the binding of [3H]-DHA to rat brain membrane preparations with an IC50 of 12 nM. It is applicable in research related to hypertension, pheochromocytoma, myocardial infarction, arrhythmia, angina, and hypertrophic cardiomyopathy.

4-Hydroxy propranolol-D7 hydrochloride is a deuterated compound of 4-Hydroxy propranolol hydrochloride (T10150). 4-Hydroxy propranolol hydrochloride has a CAS number of 14133-90-5. 4-Hydroxypropranolol hydrochloride is an active metabolite of Propranolol, with a potency comparable to Propranolol. It inhibits β1- and β2-adrenergic receptors (pA2s: 8.24 and 8.26).

Propranolol hydrochloride (Standard) is the standard substance of Propranolol hydrochloride, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Propranolol hydrochloride is a widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.

4-Hydroxy Propranolol HCL (Standard) is a reference standard for research and analysis in studies involving 4-Hydroxy Propranolol HCL. 4-Hydroxypropranolol hydrochloride is an active metabolite of Propranolol, with a potency comparable to Propranolol. It inhibits β1- and β2-adrenergic receptors (pA2s: 8.24 and 8.26).

Propranolol‑D7 hydrochloride (Standard) is a reference standard of Propranolol‑D7 Hydrochloride intended for quantitative analysis, quality control, and related biochemical research applications

Propranolol-[D5] (Standard) is a reference standard of Propranolol-[D5] intended for quantitative analysis, quality control, and related biochemical research applications.

Norpropranolol hydrochloride is the active metabolite of Propranolol.

(±)-Desisopropylpropranolol (N-Desisopropylpropranolol) is a metabolite of Propranolol. Propranolol acts as a non-selective β-adrenergic receptor (βAR) antagonist with high affinity for both β1AR and β2AR, having Ki values of 1.8 nM and 0.8 nM, respectively. It inhibits the binding of [3H]-DHA to rat brain membrane preparations with an IC50 of 12 nM. Propranolol is used in studies related to hypertension, pheochromocytoma, myocardial infarction, arrhythmias, angina pectoris, and hypertrophic cardiomyopathy.

Phosphatase-IN-1 (compound II-8), a propranolol derivative, acts as an inhibitor of phosphatidate phosphatase (Pah). It binds to MoPah1 with an affinity constant of 19.8 μM, demonstrating growth inhibition of plant pathogens and anti-fungal properties, while exhibiting no toxicity towards rice seedlings and wheat heads [1].

(R)-(+)-Atenolol ((R)-Atenolol) is a cardioselective beta-1 adrenergic blocker, which properties are similar to propranolol, but without a negative inotropic effect.

Butocrolol is an amino alcohol derivative that exhibits β-blocker, antiarrhythmic, and local anesthetic properties. This compound shares sympathetic inhibition and antiarrhythmic effects similar to propranolol but has weaker local anesthetic effects.

Butocrolol is an amino alcohol derivative characterized by its β-adrenergic blocking, antiarrhythmic, and local anesthetic properties. Its efficacy in sympathetic blockade and antiarrhythmic effects is similar to propranolol, although it exhibits lower local anesthetic activity.